Article citationsMore>>

Oteng‐Ntim, E., Pavord, S., Howard, R., Robinson, S., Oakley, L., Mackillop, L., et al. (2021) Management of Sickle Cell Disease in Pregnancy. a British Society for Haematology Guideline. British Journal of Haematology, 194, 980-995.
https://doi.org/10.1111/bjh.17671

has been cited by the following article:

• TITLE: Managing the Pregnant Woman with Sickle Cell Disease—A Practical Guide for the Obstetrician

  AUTHORS: Papa Essilfie

  KEYWORDS: SCD-Sickle Cell Disease, BUE & CR-Blood Urea, Electrolytes and Creatinine, LFT-Liver Function Tests, CTPA-Computerized Pulmonary Angiogram, FAS-Foetal Anomaly Scan, ACS-Acute Chest Syndrome RCOG VTE Score-Royal College of Obstetricians/Gynaecologists Thromboembolism Score, MEOWS-Modified Enhanced Warning Score, MDT-Multidisciplinary Team, NSAIDS-Nonsteroidal Anti-Inflammatory Drugs

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.16 No.2, February 3, 2026

  ABSTRACT: Sickle cell disease is a multi-systemic, chronic condition characterized by acute episodes (referred to as crisis), persistent anaemia, organ infarction/damage and a shortened lifespan. It is the most common inherited blood disorder in humans and affects millions of people worldwide. Pregnancy in sickle cell patients is fraught with several complications and often results in increased perinatal morbidity and occasionally maternal mortality. Managing a pregnant woman with sickle cell disease can be very challenging. The following is a short update and guide for the busy, practising Obstetrician in a District General Hospital setting who may be faced with such a challenge.